RankingsPricing
  1. JP-listed companies
  2. KAKEN PHARMACEUTIAL CO., LTD.
  3. Financials
  4. Cash from financing

KAKEN PHARMACEUTIAL CO., LTD.【JP:4521】

Market cap
¥188.4B
P/E ratio
67.5x
SummaryFinancialsDividendsHistorySegmentsOwnershipWorkforce
Period EndCash from financing (Million JPY)YoY (%)
Mar 31, 2025-5,369-5.11%
Mar 31, 2024-5,658-19.06%
Mar 31, 2023-6,990-14.01%
Mar 31, 2022-8,129-7.12%
Mar 31, 2021-8,752-13.97%
Mar 31, 2020-10,173+6.81%
Mar 31, 2019-9,524-0.06%
Mar 31, 2018-9,530-2.76%
Mar 31, 2017-9,800+63.77%
Mar 31, 2016-5,984-24.25%
Mar 31, 2015-7,900

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)